BRGX · Bioregenx, Inc.
Market Cap
$7.77M
Shares
971.58M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.85M
-20.8%
FY2025
Net Income
-$1.54M
+93.3%
FY2025
Gross Margin
81.08%
+10.2pp
FY2025
Operating Margin
-67.08%
+905.7pp
FY2025
Diluted EPS
$0.00
+100%
FY2025
Operating Cash Flow
$38.97K
+112%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| $1.77M | $1.85M | $2.34M | $3.41M | $42.16K | $198.58K | |
| $319.63K | $350.86K | $681.69K | $1.1M | $0 | $554 | |
| $1.45M | $1.5M | $1.66M | $2.31M | $42.16K | $198.03K | |
| — | 81.08% | 70.87% | 67.76% | 100% | 99.72% | |
| — | $31.75K | $0 | $257.72K | — | — | |
| $1.81M | $2.01M | $5.85M | $5.23M | — | — | |
| $75.64K | $75.08K | $2.22M | $3579 | — | — | |
| $2.55M | $2.75M | $24.42M | $5.72M | $120.47K | $363.15K | |
| -$1.1M | -$1.24M | -$22.76M | -$3.41M | -$78.31K | -$165.12K | |
| — | -67.08% | -972.75% | -99.92% | -185.74% | -83.15% | |
| -$1.03M | -$1.17M | -$20.54M | -$3.41M | — | — | |
| $302.43K | $299.58K | $290.66K | $292.19K | $0 | — | |
| — | — | — | -$461.51K | $0 | $68.25K | |
| -$1.75M | — | — | -$1.28M | -$78.31K | -$96.87K | |
| $0 | — | — | $0 | $0 | $0 | |
| -$1.3M | -$1.54M | -$23.05M | -$3.6M | -$78.31K | -$96.87K | |
| — | -83.23% | -985.17% | -105.53% | -185.74% | -48.78% | |
| -$1.3M | -$1.55M | -$23.05M | -$3.58M | -$117.31K | -$261.87K | |
| USD/shares | $0.00 | $0.00 | -$0.03 | -$0.01 | $0.00 | $0.00 |
| USD/shares | $0.00 | $0.00 | -$0.03 | -$0.01 | $0.00 | $0.00 |
| shares | — | 959.71M | 912.37M | 639.78M | 269.75M | 269.75M |
| shares | — | 959.71M | 912.37M | 639.78M | 269.75M | 269.75M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
5.03×
Health Information Services median 1.66×
EV/EBIT
—
Health Information Services median 27.11×
P/E (TTM)
—
Health Information Services median 37.07×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2022 | FY2021 |
|---|---|---|---|---|
| Nutritional | $1,628,306 | $1,824,723 | — | — |
| Medical Testing | $207,934 | $587,617 | — | — |
| Wellness Devices | $25,419 | $186,296 | — | — |
| Other Sales | $884 | $3,203 | — | — |
| Findit Services | — | — | $42,159 | $197,447 |
| Sales of Essential Oils | — | — | $0 | $1,137 |